Adam MacNeil; Pierre E. Rollin

Summary

Adam MacNeil; Pierre E. Rollin Ebola and Marburg Hemorrhagic Fevers…

From an occupation-based risk standpoint, prophylactic vaccination will be clearly a valuable preventive measure, both for individuals with potential exposure in the laboratory or through ecological work, as well as medical and public health personal involved in hands-on outbreak response activities.
When we consider those at risk of endemic exposure to EBOV or MARV—the bottom billion—the potential value of prophylactic vaccination becomes murky. A scenario in which one envisions applying vaccine across the entire endemic population in sub-Saharan Africa is unrealistic.
Source: Wikisource

Adam MacNeil; Pierre E. Rollin Ebola and Marburg Hemorrhagic Fevers…

While challenging, efforts to combine control of these diseases with other NTDs, through mechanisms such as integrated surveillance and improvement of health systems, would provide a combined benefit to populations in rural central Africa. While multiple candidate vaccines and anti-viral therapies against EBOV and MARV are currently in development, classical public health surveillance and outbreak control guidelines will likely remain the cornerstone of disease control. However, modern therapies have the potential to minimize the number of EHF and MHF deaths in outbreak settings.
Source: Wikisource

Adam MacNeil; Pierre E. Rollin Ebola and Marburg Hemorrhagic Fevers…

The scenario that either a pathogenic filovirus may enter (and be transmitted among swine) or that mutations in REBOV may result in a virus pathogenic to humans should continue to be considered in global surveillance efforts. In addition to the direct impact on human health, the potential economic impact on agricultural production, if swine (or other livestock) are a direct or perceived threat for transmission of filoviruses, would likely be devastating to a local or regional economy.
Source: Wikisource

Get perspective with Kwize: daily news enlightened by great literature